search
Back to results

Effectiveness of Magnetic Stimulation in the Treatment of Female UUI.

Primary Purpose

Urinary Incontinence, Urinary Incontinence, Urge, Pelvic Floor Disorders

Status
Recruiting
Phase
Not Applicable
Locations
Slovenia
Study Type
Interventional
Intervention
Extracorporeal magnetic stimulation
Sham
Sponsored by
University Medical Centre Ljubljana
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Urinary Incontinence focused on measuring urgency urinary incontinence, urinary incontinence, magnetic stimulation, urinary urgency

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: urgency urinary incontinence proved by urodynamic studies 18 years of age Exclusion Criteria: pregnancy cystitis or other active infections stress or mixed urinary incontinence prolapse of pelvic organs with POP-Q score greated than 2 fecal incontinence severe medical conditions (e.g. active treatment of cancer) connective tissue disease neurologic disease

Sites / Locations

  • Department of Gynecology, Division of Gynecology and Obstetrics, Ljubljana University Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Active group

Sham group

Arm Description

We are using an extracorporeal magnetic stimulation chair with two magnetic stimulators, one under the seat and one in the backrest, that generate the magnetic field. The treatment lasts for 30 minutes and has 5 steps. Each step has a defined duration and a defined frequency of magnetic field pulsations. In each step, it is also defined, which of the magnetic field generators are working. The pulsations last for 6 seconds followed by 6 seconds of rest. Step 1: 10Hz, 7 minutes, 6 seconds on, 6 seconds off, both stimulators generate the magnetic field. Step 2: 10Hz, 4 minutes, the stimulator under the seat generates the magnetic field. Step 3: 10Hz, 7 minutes, the stimulator in the backrest generates the magnetic field. Step 4: 30Hz, 10 minutes, both stimulators generate the magnetic field. Step 5: After 5 minutes, both stimulators generate the magnetic field. During the treatment, we adjusted the magnetic field density. It varied from 2-100%. The maximum was 3 Teslas.

We are using extracorporeal magnetic stimulation, a chair with two magnetic stimulators, one under the seat and one in the backrest, that generate the magnetic field. The treatment lasts for 30 minutes and has 5 steps. We used the same program as in the active group with the difference that the magnetic field density was always at 2% so the effects of the pulsating are negligible.

Outcomes

Primary Outcome Measures

Change in the ICIQ-UI SF score
Difference in the score of the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) questionnaire. The scoring scale is 0-21 points. Lower score means better outcome.
Change in voiding diary 1
Difference in the mean voided volume. Higher mean voided volume means better outcome.
Change in voiding diary 2
Difference in the mean number of incontinence episodes. Lower number of incontinence episodes means better outcome.
Change in voiding diary 3
Difference in the mean number of micturitions. Lower number of micturitions means better outcome.
Change in urodynamic studies 1
Difference in the volume at first desire to void. Higher volume means better outcome.
Change in urodynamic studies 2
Difference in the maximum cystometric capacity. Higher volume means better outcome.

Secondary Outcome Measures

Change in UDI-6 score
Difference in the score of the Urinary Distress Inventory Short Form (UDI-6) questionnaire. Score values go from 0 to 100. Lower score means better outcome.
Change in IIQ-7 score
Difference in the score of the Incontinence Impact questionnaire Short Form (IIQ-7) questionnaire. Scores go from 0 to 100 with lower score meaning better outcome.
Change in PISQ-12 score
Difference in the score of The Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12). Scores go from 0 to 48 with higher score meaning better outcome.
Change in King's Health questionnaire
Difference in the score of the King's health questionnaire. Scores go from 0 to 100. With lower score meaning better outcome.

Full Information

First Posted
January 19, 2023
Last Updated
February 9, 2023
Sponsor
University Medical Centre Ljubljana
Collaborators
University of Ljubljana, Faculty of Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT05735522
Brief Title
Effectiveness of Magnetic Stimulation in the Treatment of Female UUI.
Official Title
Randomized, Sham-controlled Study on the Effectiveness of Magnetic Stimulation in the Treatment of Female Urgency Urinary Incontinence.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 25, 2021 (Actual)
Primary Completion Date
February 2023 (Anticipated)
Study Completion Date
May 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Medical Centre Ljubljana
Collaborators
University of Ljubljana, Faculty of Medicine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Urinary incontinence is becoming an increasingly common health, social and economic problem. The prevalence of urinary incontinence is estimated at 55% of the entire female population. Urgency urinary incontinence (UUI) is the least common subtype of urinary incontinence but has debilitating symptoms that lead to a decrease in quality of life. Ultimately, the urogynegology field does not have many successful types of treatments for this specific subtype. Extracorporeal magnetic stimulation of the pelvic floor is a type of conservative management that produces a magnetic field, which induces controlled depolarization of the nerves, resulting in pelvic muscle contraction and sacral S2-S4 roots neuromodulation. Therefore, it relieves symptoms of UUI and improves quality of life. There was no randomized, sham-controlled study published that researched the effectiveness of magnetic stimulation in the treatment of UUI that evaluated the success with subjective and objective methods, such as urodynamic studies. The aim of this study was to assess the efficacy of magnetic stimulation in the treatment of urgency urinary incontinence.
Detailed Description
RATIONALE: The FDA approved extracorporeal magnetic stimulation as a form of conservative treatment of urinary incontinence in 1998. Since then, the studies focused mainly on magnetic stimulation's effectiveness in treating stress urinary incontinence. There are five studies that assessed the efficacy of magnetic stimulation in the treatment of urgency urinary incontinence. Only one was randomized and sham-controlled, others were not. Three studies used urodynamic studies to assess the effectiveness of magnetic stimulation treatment, but those studies were not randomized or sham-controlled. The EAU guidelines, therefore, do not recommend extracorporeal magnetic stimulation as a treatment option for urinary incontinence for the lack of evidence. AIM OF THE STUDY: The study will evaluate the efficacy of magnetic stimulation as a type of conservative treatment in patients with urgency urinary incontinence. After evaluating previously conducted studies, the investigators decided to conduct the first randomized, sham-controlled study that evaluated the effectiveness of magnetic stimulation as a treatment for urgency urinary incontinence with subjective and objective measures. METHODS: the study will be randomized and sham controlled with 40 enrolled patients. The patients will be allocated in the active or sham arm in a ratio of 2:1. The patients will be recruited from the UMC Ljubljana outpatient urogynecologic clinic. All eligible patients will be invited to participate in our study by phone. STATISTICAL ANALYSES: The results will be analysed with the Kolmogorov-Smirnov test and two-way ANOVA with repeated measures.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence, Urinary Incontinence, Urge, Pelvic Floor Disorders
Keywords
urgency urinary incontinence, urinary incontinence, magnetic stimulation, urinary urgency

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Active group
Arm Type
Active Comparator
Arm Description
We are using an extracorporeal magnetic stimulation chair with two magnetic stimulators, one under the seat and one in the backrest, that generate the magnetic field. The treatment lasts for 30 minutes and has 5 steps. Each step has a defined duration and a defined frequency of magnetic field pulsations. In each step, it is also defined, which of the magnetic field generators are working. The pulsations last for 6 seconds followed by 6 seconds of rest. Step 1: 10Hz, 7 minutes, 6 seconds on, 6 seconds off, both stimulators generate the magnetic field. Step 2: 10Hz, 4 minutes, the stimulator under the seat generates the magnetic field. Step 3: 10Hz, 7 minutes, the stimulator in the backrest generates the magnetic field. Step 4: 30Hz, 10 minutes, both stimulators generate the magnetic field. Step 5: After 5 minutes, both stimulators generate the magnetic field. During the treatment, we adjusted the magnetic field density. It varied from 2-100%. The maximum was 3 Teslas.
Arm Title
Sham group
Arm Type
Sham Comparator
Arm Description
We are using extracorporeal magnetic stimulation, a chair with two magnetic stimulators, one under the seat and one in the backrest, that generate the magnetic field. The treatment lasts for 30 minutes and has 5 steps. We used the same program as in the active group with the difference that the magnetic field density was always at 2% so the effects of the pulsating are negligible.
Intervention Type
Device
Intervention Name(s)
Extracorporeal magnetic stimulation
Intervention Description
Extracorporeal magnetic stimulation is a technique based on Faraday's law of magnetic induction, approved by the United States Food and Drug Administration in 1998, for conservative treatment of urinary incontinence. It generates electrical activity, which induces controlled depolarization of the nerves, resulting in pelvic muscle contraction and sacral S2-S4 roots neuromodulation. The patient seats in the chair fully clothed.
Intervention Type
Other
Intervention Name(s)
Sham
Intervention Description
The same chair as is used in the active group with the magnetic field density at the lower 2% resulting in negligible efficacy.
Primary Outcome Measure Information:
Title
Change in the ICIQ-UI SF score
Description
Difference in the score of the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) questionnaire. The scoring scale is 0-21 points. Lower score means better outcome.
Time Frame
Before the treatment and immediately after the treatment, 3 months after the treatment, 6 months after the treatment and 12 months after the treatment.
Title
Change in voiding diary 1
Description
Difference in the mean voided volume. Higher mean voided volume means better outcome.
Time Frame
Before the treatment and immediately after the treatment, 3 months after the treatment, 6 months after the treatment and 12 months after the treatment.
Title
Change in voiding diary 2
Description
Difference in the mean number of incontinence episodes. Lower number of incontinence episodes means better outcome.
Time Frame
Before the treatment and immediately after the treatment, 3 months after the treatment, 6 months after the treatment and 12 months after the treatment.
Title
Change in voiding diary 3
Description
Difference in the mean number of micturitions. Lower number of micturitions means better outcome.
Time Frame
Before the treatment and immediately after the treatment, 3 months after the treatment, 6 months after the treatment and 12 months after the treatment.
Title
Change in urodynamic studies 1
Description
Difference in the volume at first desire to void. Higher volume means better outcome.
Time Frame
Before the treatment and 3 months after the treatment.
Title
Change in urodynamic studies 2
Description
Difference in the maximum cystometric capacity. Higher volume means better outcome.
Time Frame
Before the treatment and 3 months after the treatment.
Secondary Outcome Measure Information:
Title
Change in UDI-6 score
Description
Difference in the score of the Urinary Distress Inventory Short Form (UDI-6) questionnaire. Score values go from 0 to 100. Lower score means better outcome.
Time Frame
Before the treatment and immediately after the treatment, 3 months after the treatment, 6 months after the treatment and 12 months after the treatment.
Title
Change in IIQ-7 score
Description
Difference in the score of the Incontinence Impact questionnaire Short Form (IIQ-7) questionnaire. Scores go from 0 to 100 with lower score meaning better outcome.
Time Frame
Before the treatment and immediately after the treatment, 3 months after the treatment, 6 months after the treatment and 12 months after the treatment.
Title
Change in PISQ-12 score
Description
Difference in the score of The Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12). Scores go from 0 to 48 with higher score meaning better outcome.
Time Frame
Before the treatment and immediately after the treatment, 3 months after the treatment, 6 months after the treatment and 12 months after the treatment.
Title
Change in King's Health questionnaire
Description
Difference in the score of the King's health questionnaire. Scores go from 0 to 100. With lower score meaning better outcome.
Time Frame
Before the treatment and immediately after the treatment, 3 months after the treatment, 6 months after the treatment and 12 months after the treatment.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: urgency urinary incontinence proved by urodynamic studies 18 years of age Exclusion Criteria: pregnancy cystitis or other active infections stress or mixed urinary incontinence prolapse of pelvic organs with POP-Q score greated than 2 fecal incontinence severe medical conditions (e.g. active treatment of cancer) connective tissue disease neurologic disease
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
David Lukanović, MD
Phone
+38615226200
Email
david.lukanovic@kclj.si
First Name & Middle Initial & Last Name or Official Title & Degree
Adolf Lukanović, MD, PhD
Phone
+38631310797
Email
adolf.lukanovic@guest.arnes.si
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Adolf Lukanović, MD, PhD
Organizational Affiliation
Department of Gynecology, Division of Gynecology and Obstetrics, Ljubljana University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Gynecology, Division of Gynecology and Obstetrics, Ljubljana University Medical Center
City
Ljubljana
ZIP/Postal Code
1000
Country
Slovenia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Borut Kobal, MD, PhD
Phone
+38615226200
Email
borut.kobal@kclj.si

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data obtained through this study may be provided to qualified researchers with academic interest in UUI.
IPD Sharing Time Frame
Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 20 months. Extensions will be considered on a case-by-case basis
IPD Sharing Access Criteria
Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of the principal investigator.For more information or to submit a request, please contact david.lukanovic@kclj.si
Citations:
PubMed Identifier
34768730
Citation
Lukanovic D, Kunic T, Batkoska M, Matjasic M, Barbic M. Effectiveness of Magnetic Stimulation in the Treatment of Urinary Incontinence: A Systematic Review and Results of Our Study. J Clin Med. 2021 Nov 8;10(21):5210. doi: 10.3390/jcm10215210.
Results Reference
background
PubMed Identifier
31235706
Citation
He Q, Xiao K, Peng L, Lai J, Li H, Luo D, Wang K. An Effective Meta-analysis of Magnetic Stimulation Therapy for Urinary Incontinence. Sci Rep. 2019 Jun 24;9(1):9077. doi: 10.1038/s41598-019-45330-9.
Results Reference
background
PubMed Identifier
24118165
Citation
Yamanishi T, Homma Y, Nishizawa O, Yasuda K, Yokoyama O; SMN-X Study Group. Multicenter, randomized, sham-controlled study on the efficacy of magnetic stimulation for women with urgency urinary incontinence. Int J Urol. 2014 Apr;21(4):395-400. doi: 10.1111/iju.12289. Epub 2013 Oct 14.
Results Reference
background

Learn more about this trial

Effectiveness of Magnetic Stimulation in the Treatment of Female UUI.

We'll reach out to this number within 24 hrs